Metastatic Colo-Rectal Cancer, 2005-2008: Treatment results

Metastatic Colo-Rectal Cancer, 2005-2008: Treatment results

Show other versions (1)

Introduction: Colo-rectal cancer has 10% prevalence, among all of the cancer proportionally and also it is the third common cancer in the both sexes. Two recently introduced active drugs in the treatment of advanced colorectal cancer (ACC) are irinotecan and oxaliplatin. The combinations of oxalipla...

Full description

Bibliographic Details
Main Authors: Mozaffar Aznab, A Tabarroki, Gh Mohsseni, F Farshian, K Kavyani
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2009-12-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Oxalliplatin
Irrinotecan
Colorectal cancer
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/228

Similar Items

Similar Items